Literature DB >> 1281145

The prognostic value of prostate-specific antigen and prostatic acid phosphatase in serum of patients with prostate cancer after orchidectomy.

S Dutkiewicz1, B Stawarz, A Lypka, H Zieliński.   

Abstract

Correlations between the serum levels of PAP and PSA before and 1, 3 and 6 months after orchidectomy in 27 prostatic cancer patients (advanced clinical stages C and D according to Whitemore scale) were studied. The PSA values correlated more distinctly than PAP with the general clinical condition. PSA is a reliable tumour marker when used at regular intervals, especially for monitoring therapeutic results. A high preoperative PSA level correlates with a high postoperative level and progression of the disease.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1281145     DOI： 10.1007/BF02550635

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  6 in total

1.  Androgen receptors in cancer of the prostate. Correlation with the stage and grade of the tumor.

Authors:  F K Habib; S Odoma; A Busuttil; G D Chisholm
Journal:  Cancer       Date:  1986-06-15       Impact factor: 6.860

2.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

3.  Cancer statistics, 1989.

Authors:  E Silverberg; J A Lubera
Journal:  CA Cancer J Clin       Date:  1989 Jan-Feb       Impact factor: 508.702

Review 4.  Prostatic acid phosphatase: its current clinical status.

Authors:  J E Heller
Journal:  J Urol       Date:  1987-06       Impact factor: 7.450

Review 5.  New methods of endocrine management of prostatic cancer.

Authors:  J A Smith
Journal:  J Urol       Date:  1987-01       Impact factor: 7.450

6.  [The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].

Authors:  T A Stamey
Journal:  Urologe A       Date:  1990-03       Impact factor: 0.639
  6 in total
  3 in total

1.  Relationship between prostate-specific antigen, prostate volume, retention volume and age in benign prostatic hypertrophy (BPH).

Authors:  S Dutkiewicz; A Witeska; K Stepień
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  Effect of digital rectal examination on plasma prostate-specific antigen (PSA).

Authors:  S Dutkiewicz; K Stepień; A Witeska
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  The deiodination of thyroxine to triiodothyronine in the testes of patients with prostate cancer.

Authors:  S Dutkiewicz; A Witeska; A Nauman
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.